Clinical Trial Results: GK Activator (2)

Product Name: GK Activator (2)
Date of Report: To be Published
Phase: II
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Product Name: GK Activator (2)
Date of Report: To be Published
Phase: II
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Product Name: GK Activator (2)
Date of Report: To be Published
Phase: II
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients WIth Type 2 Diabetes

Product Name: GK Activator (2)
Date of Report: To be Published
Phase: II
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes

Product Name: GK Activator (2)
Date of Report: To be Published
Phase: I
A Multiple Ascending Dose Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Glimepiride.

Product Name: GK Activator (2)
Date of Report: To be Published
Phase: I
A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.

Product Name: GK Activator (2)
Date of Report: To be Published
Phase: I
A Study to Evaluate the Effect of GK Activator (2) on QT Interval in Patients With Type 2 Diabetes Mellitus.

Product Name: GK Activator (2)
Date of Report: To be Published
Phase: I
A Drug-Drug Interaction Study of GK Activator (2) and Ethanol in Patients With Type 2 Diabetes.

Product Name: GK Activator (2)
Date of Report: To be Published
Phase: I
A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.

Product Name: GK Activator (2)
Date of Report: To be Published
Phase: I
A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.

Product Name: GK Activator (2)
Date of Report: To be Published
Phase: I
A Study of the Pharmacokinetics/Pharmacodynamics of GK Activator (2) in Type 2 Diabetes Patients With Hepatic Impairment.